Notably, miR-30a was also reported to inhibit cell growth in PCa cells without expressing androgen receptors by targeting MYBL2, FOXD1, and SOX4 [33] and reduced tumorigenicity in vivo models of PCa [34]. This evidence concerns the gene FOXD1 and posterior cortical atrophy.